Healthcare IT News April 3, 2024
Citing compliance strains on providers and others, and the need to maintain patient care continuity, more than 200 virtual care stakeholders urged the agency to release its regulatory scheme for the prescribing of controlled substances through telehealth.
With current pandemic-era flexibilities for telemedicine set to expire at the end of 2024, several telehealth groups and major health systems are calling on the U.S. Drug Enforcement Administration to work faster in crafting a new proposed rule regulating the prescribing of controlled substances via telehealth.
The American Telemedicine Association, the Alliance for Connected Care, the Consumer Technology Association, the Partnership to Advance Virtual Care, Allina Health, Johns Hopkins, Mass General Brigham and HIMSS (parent company of Healthcare IT News) were just some...
Today's Sponsors
Today's Sponsor